Sleep Disorders Pharmaceutical and Healthcare Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Sleep Disorders Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the pipeline landscape for sleep disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Restless Legs Syndrome, Nocturia and Insomnia, and features dormant and discontinued projects.

Restless Legs Syndrome is a neurologic disorder with a core feature of a distressing, irresistible need or urge to move the legs. Risk factors for RLS include low iron levels, kidney failure, Parkinson's disease, diabetes mellitus, rheumatoid arthritis, and pregnancy.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385279-sleep-disorders-drug-development-pipeline-review-2017

Nocturia, or nocturnal polyuria, describes the excessive urination during night time. Nocturia becomes more common with age and may be symptomatic of the use of diuretic substances, prescription drugs, edema from heart failure, insomnia, pain and prostate or bladder disorders.

Finally, insomnia is a sleep disorder that is characterized by difficulty in falling or staying asleep. Symptoms include difficulty falling asleep at night, waking up during the night, irritability, depression and anxiety.

The size of these pipelines ranges from eight products in restless legs syndrome and nocturia to 31 in insomnia. Across all three of these indications there is a diverse range of molecular targets due to the different pathologies of the indications. The most common targets for restless legs syndrome, nocturia and insomnia therapeutics are D2 dopamine receptor, vasopressin V2 receptor and orexin receptor, respectively.

Scope
- Which companies are the most active within the pipeline for sleep disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of sleep disorders?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Sleep Disorders Report Coverage 7
2.2 Restless Legs Syndrome - Overview 7
2.3 Nocturia - Overview 7
2.4 Insomnia - Overview 7
3 Therapeutics Development 8
3.1 Restless Legs Syndrome 8
3.2 Nocturia 11
3.3 Insomnia 14
4 Therapeutics Assessment 21
4.1 Restless Legs Syndrome 21
4.2 Nocturia 27
4.3 Insomnia 33
5 Companies Involved in Therapeutics Development 39
5.1 Restless Legs Syndrome 39
5.2 Nocturia 42
5.3 Insomnia 44
6 Dormant Projects 53
6.1 Restless Legs Syndrome 53
6.2 Nocturia 53
6.3 Insomnia 54
7 Discontinued Products 56
7.1 Restless Legs Syndrome 56
7.2 Insomnia 56
8 Product Development Milestones 58
8.1 Restless Legs Syndrome 58
8.2 Nocturia 63
…Continued

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/sleep-disorders-pharmaceutical-and-healthcare-pipeline-review-2017/250082

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250082

Latest News

Wiggins scores 29 as Wolves rally past Raptors 115-109

Jan 21, 2018

MINNEAPOLIS — There was no Jimmy Butler, practically no Karl-Anthony Towns in the first half, and the visiting Toronto Raptors were shooting 54 percent. These are the types of games the Minnesota Timberwolves of the last few years didn't win. This season's revamped team is showing the toughness needed to compete with the league's top teams. Andrew Wiggins scored 29 points, Towns had all 22 of his points in the second half and the Wolves rallied from 11 down to beat the Toronto Raptors 115-109 on Saturday night. "We've got a lot of guys that know how to play," Wiggins...

Coyotes snap losing streak to Blues with 5-2 win

Jan 21, 2018

ST. LOUIS — Christian Dvorak had no idea the two goals he scored Saturday night helped the Arizona Coyotes end a long run of futility against the St. Louis Blues. "Wow, we lost 12 in a row to them?" Dvorak said. "That makes this even better." Dvorak sparked a four-goal first period, Antti Raanta made 25 saves and the Coyotes beat St. Louis 5-2 for their first win in the series since a 3-2 overtime triumph on Nov. 12, 2013. The 12-game skid was tied for the longest current streak of its kind in the NHL; Chicago has won 12...

The Latest: Miocic keeps UFC heavyweight title with decision

Jan 21, 2018

BOSTON — The Latest on UFC 220 in Boston, with the heavyweight and light heavyweight titles up for grabs (all times local): 12:55 a.m. Stipe Miocic set the UFC heavyweight record with his third straight successful title defense, turning the anticipated slugfest against Francis Ngannou into a methodical ground-and-pound bout in the main event of UFC 220. Miocic won 50-44 on all three scorecards early Sunday and was never seriously tested by the raw but unrefined Ngannou. Miocic (18-2) and Ngannou (11-2) had UFC fans buzzing with perhaps the most-hyped heavyweight title bout since Brock Lesnar was the class of...

Mitchell gets 23, Jazz end Clippers' streak with 125-113 win

Jan 21, 2018

SALT LAKE CITY — The offensively challenged Utah Jazz found a way to score points in droves Saturday night. Donovan Mitchell scored 23 points and helped Utah close out a 125-113 win over the Los Angeles Clippers with their second-highest point total this season. Despite missing starting guard Rodney Hood because of a leg injury, Utah set season bests for points in the first quarter (39) and first half (76). It never trailed while ending the Clippers' six-game winning streak. "Just playing with force," Jazz center Rudy Gobert said. "Being aggressive. Moved the ball. Our defense got a lot of...

Sharp-shooting Lillard gets 31 points, Blazers beat Mavs

Jan 21, 2018

PORTLAND, Ore. — Damian Lillard hit his first nine shots — including seven 3-pointers — en route to 31 points, and the Portland Trail Blazers beat the Dallas Mavericks 117-108 on Saturday night. Lillard shot 10 of 15 from the floor and handed out nine assists. CJ McCollum added 26 points for Portland, which won its third straight game overall and season-best sixth straight at home. Portland tied a season high by making 18 3-pointers. Six Blazers hit at least two shots from behind the arc. Evan Turner scored 17 points and Al-Farouq Aminu had 13 for Portland. Wesley Matthews...

Get your 24-hour live updates here in Ultimate Sports Daily. We deliver content from all regions so that you won’t miss out on any single event.

Contact us: sales@ultimatesportsda.com